Evidence map›Paper›PMID 31340764›Full record

ArticleBMC genomics2019

Insertion/deletion-activated frame-shift fluorescence protein is a sensitive reporter for genomic DNA editing.

Akhilesh Kumar, Michael D Birnbaum, Balaji T Moorthy, Jayanti Singh, Anna Palovcak, Devang M Patel, Fangliang Zhang

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Enrichment strategies to enhance genome editing.Journal of biomedical science · 2023
    Review
  3. Evaluate the guide RNA effectivenessFrontiers in plant science · 2023
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Akhilesh KumarDepartment of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, 33136, USA.
Michael D BirnbaumDepartment of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, 33136, USA.
Balaji T MoorthyDepartment of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, 33136, USA.
Jayanti SinghDepartment of Otolaryngology, University of Miami, Miller School of Medicine, Miami, FL, 33136, USA.
Anna PalovcakDepartment of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, FL, 33136, USA.
Devang M PatelDepartment of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, 33136, USA.
Fangliang ZhangDepartment of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, 33136, USA. FZhang2@miami.edu.ORCID http://orcid.org/0000-0002-8373-192X
University of Miami · US

Funding

Regulation of cadherin-based cell adhesions by talin proteolysis and arginylationR01GM107333 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ZHANG, FANGLIANG · 2013 to 2017
$1.5M
DOD Prostate Cancer Research Program PC140622NIGMS NIH HHS R01 GM107333NIH HHS R01#GM107333
6 · The paper itself

Abstract

backgroundReporter methods to quantitatively measure the efficiency and specificity of genome editing tools are important for the development of novel editing techniques and successful applications of available ones. However, the existing methods have major limitations in sensitivity, accuracy, and/or readiness for in vivo applications. Here, we aim to develop a straight-forward method by using nucleotide insertion/deletion resulted from genome editing. In this system, a target sequence with frame-shifting length is inserted after the start codon of a cerulean fluorescence protein (CFP) to inactivate its fluorescence. As such, only a new insertion/deletion event in the target sequence will reactivate the fluorescence. This reporter is therefore termed as "Insertion/deletion-activated frame-shift fluorescence protein". To increase its traceability, an internal ribosome entry site and a red fluorescence protein mCherryFP are placed downstream of the reporter. The percentage of CFP-positive cells can be quantified by fluorescence measuring devices such as flow cytometer as the readout for genome editing frequency.

resultsTo test the background noise level, sensitivity, and quantitative capacity of this new reporter, we applied this approach to examine the efficiency of genome editing of CRISPR/Cas9 on two different targeting sequences and in three different cell lines, in the presence or absence of guide-RNAs with or without efficiency-compromising mutations. We found that the insertion/deletion-activated frame-shift fluorescence protein has very low background signal, can detect low-efficiency genome editing events driven by mutated guideRNAs, and can quantitatively distinguish genome editing by normal or mutated guideRNA. To further test whether the positive editing event detected by this reporter indeed correspond to genuine insertion/deletion on the genome, we enriched the CFP-positive cells to examine their fluorescence under confocal microscope and to analyze the DNA sequence of the reporter in the genome by Sanger sequencing. We found that the positive events captured by this reporter indeed correlates with genuine DNA insertion/deletion in the expected genome location.

conclusionThe insertion/deletion-activated frame-shift fluorescence protein reporter has very low background, high sensitivity, and is quantitative in nature. It will be able to facilitate the development of new genome editing tools as well as the application of existing tools.

Indexed as

Frameshift MutationGene EditingINDEL MutationAnimalsCHO CellsCodon, InitiatorCricetulusCRISPR-Cas SystemsFibroblastsFluorescenceGenes, ReporterHEK293 CellsHumansInternal Ribosome Entry SitesLuminescent ProteinsMiceCodon, InitiatorInternal Ribosome Entry SitesLuminescent ProteinsRNA, Guide, CRISPR-Cas SystemsCRIPSR-Cas9Genome editingIn-delInsertion-deletionNHEJReporter

Identifiers

PMID31340764
PMCPMC6657097
OpenAlexW2963214711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.